Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leysan Il'darovna Myasoutova"'
Autor:
Il'dar Gazimdzhanovich Salikhov, Svetlana Anatol'evna Lapshina, Leysan Il'darovna Myasoutova, Elina Rinadovna Kirillova, Raviya Gayazovna Mukhina, I G Salikhov, S A Lapshina, L I Myasoutova, E R Kirillova, R G Mukhina
Publikováno v:
Терапевтический архив, Vol 82, Iss 5, Pp 58-60 (2010)
Aim. To estimate the prevalence and impact of lower extremity peripheral vein diseases on the course of articular syndrome in osteoarthrosis (OA), to reveal the specific features of concomitant pathology, and to substantiate the necessity of its ther
Externí odkaz:
https://doaj.org/article/daf1b626f0b44eacb06ec1950507d755
Autor:
Il'dar Gazimdzhanovich Salikhov, Svetlana Anatol'evna Lapshina, Leysan Il'darovna Myasoutova, Elina Rinadovna Kirillova, Nailya Gumerovna Shamsutdinova, I G Salikhov, S A Lapshina, L I Myasoutova, E R Kirillova, N T Shamsutdinova
Publikováno v:
Терапевтический архив, Vol 81, Iss 8, Pp 70-72 (2009)
Aim. To examine efficacy and tolerance of the drug Bora-Bora in patients with osteoarthrosis. Material and methods. Bora-Bora and nimesulid were given to 20 patients with a verified diagnosis of osteoarthrosis (OA). 20 control patients received nimes
Externí odkaz:
https://doaj.org/article/91d0f7fadb7948bc90a7aa2c759d1aee
Autor:
Mariannа A. Afanasievа, S A Lapshina, Leysan Il'darovna Myasoutova, Elena V. Sukhorukova, I. F. Akhtyamov
Publikováno v:
The Bulletin of Contemporary Clinical Medicine. 9:45-51
im. Assessment the efficacy and safety of combined use of drugs «Artradol» (chondroitin sulfate) and «Artrakam» (glucosamine sulfate) in patients with osteoarthritis (OA) of the knee. Material and methods. We examined 30 patients with a diagnosis
Autor:
I G Salikhov, R Z Abdrakipov, R. Mukhina, Leysan Il'darovna Myasoutova, E L Yunusova, Z N Nigmatullina, A. Vasilyev, S A Lapshina
Publikováno v:
Современная ревматология, Vol 4, Iss 4, Pp 44-50 (2010)
Objective: to evaluate the efficacy and tolerability of adalimumab alone and in combination with basic anti-inflammatory drugs (BAIDs) in patients with rheumatoid arthritis (RA), by taking into account the specific features of the course of the disea